KURE ETF
KraneShares MSCI All China Health Care Index ETF
6160:HK is KURE's largest holding at 8.92% of the fund as of Nov 2, 2026. KURE is KraneShares MSCI All China Health Care Index ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | O | BeiGene Ltd | 8.92% | 8.9% | 342,018 | $9.62M | - | - |
| 2 | — | Innovent Biologics IncHealth Care · Biotechnology | 7.97% | 16.9% | 837,000 | $8.60M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | — | Wuxi Biologics (cayman) Inc. | 7.28% | 24.2% | 1,381,135 | $7.85M | ||
| 4 | — | Wuxi Apptec Co. Ltd. Class A | 5.47% | 29.6% | 282,920 | $5.90M | ||
| 5 | — | Jiangsu Hengrui Medicine Co Ltd Class A | 4.79% | 34.4% | 705,208 | $5.17M | ||
| 6 | — | Shenzhen Mindray Bio-Medical Electronic | 4.62% | 39.0% | 184,955 | $4.99M | ||
| 7 | — | Akeso Inc | 3.90% | 42.9% | 418,000 | $4.20M | ||
| 8 | — | Sino Biopharmaceutical Limited | 3.62% | 46.6% | 6,300,750 | $3.91M | ||
| 9 | — | CSPC Pharmaceutical Group Limited Shs | 3.39% | 50.0% | 3,636,889 | $3.66M | ||
| 10 | — | Wuxi Apptec Co Ltd Class H | 3.08% | 53.0% | 145,084 | $3.33M | ||
| 11 | — | Genscript Biotech Corp Class H | 3.04% | 56.1% | 720,000 | $3.28M | ||
| 12 | — | Hansoh Pharmaceutical Group Co Ltd | 3.03% | 59.1% | 802,000 | $3.27M | ||
| 13 | — | Yunnan Baiyao Group Co Ltd | 2.56% | 61.7% | 339,027 | $2.76M | ||
| 14 | — | Shanghai United Imaging HE Class A | 2.51% | 64.2% | 157,364 | $2.71M | ||
| 15 | — | Aier Eye Hospital Group Co Ltd | 2.14% | 66.3% | 1,770,963 | $2.31M | ||
| 16 | — | Sichuan Kelun-Biotech Biop Class H | 2.04% | 68.4% | 40,600 | $2.20M | ||
| 17 | — | 3SBio Inc | 2.03% | 70.4% | 1,256,500 | $2.19M | ||
| 18 | — | Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A | 1.95% | 72.3% | 110,234 | $2.11M | ||
| 19 | — | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.80% | 74.1% | 51,035 | $1.94M | ||
| 20 | — | Sichuan Kelun Pharmaceutical Co. Ltd. Class A | 1.75% | 75.9% | 311,816 | $1.89M | ||
| 21 | — | Pharmaron Beijing Ltd Class A | 1.67% | 77.6% | 279,475 | $1.80M | ||
| 22 | — | Sinopharm Group Co Ltd | 1.62% | 79.2% | 838,000 | $1.75M | ||
| 23 | — | Haisco Pharmaceutical Group Co. Ltd. Class A | 1.37% | 80.6% | 172,000 | $1.48M | ||
| 24 | — | Shenzhen New Industries Biomedical Engineering Co Ltd | 1.28% | 81.8% | 155,200 | $1.38M | ||
| 25 | — | Shanghai Fosun Pharmaceuti-A | 1.26% | 83.1% | 395,629 | $1.36M | ||
| 26 | — | Huadong Medicine Co Ltd | 1.24% | 84.3% | 335,441 | $1.34M | ||
| 27 | — | Asymchem Laboratories Ltd | 1.24% | 85.6% | 64,900 | $1.34M | ||
| 28 | — | Xtalpi Holdings Ltd Class A | 1.24% | 86.8% | 1,745,000 | $1.34M | ||
| 29 | — | Shanghai Pharmaceuticals Holding Co. Ltd. Class A | 1.22% | 88.0% | 524,112 | $1.32M | ||
| 30 | — | WuXi XDC Cayman Inc | 1.15% | 89.2% | 148,000 | $1.25M | ||
| 31 | — | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | 1.13% | 90.3% | 316,401 | $1.22M | ||
| 32 | — | Apt Medical Inc | 1.07% | 91.4% | 28,026 | $1.16M | ||
| 33 | — | Shanghai Allist Pharmaceuticals Co Ltd | 1.00% | 92.4% | 87,372 | $1.08M | ||
| 34 | — | Remegen Co., Ltd. | 0.94% | 93.3% | 121,000 | $1.02M | ||
| 35 | L | Legend Biotech Corp ADR | 0.93% | 94.3% | 47,528 | $1.00M | ||
| 36 | — | Beijing Tongrentang Co Ltd | 0.91% | 95.2% | 260,690 | $978.1K | ||
| 37 | — | Remegen Co Ltd_None_None | 0.90% | 96.1% | 69,004 | $967.8K | ||
| 38 | — | Shenzhen Salubris Pharmaceuticals Co Ltd | 0.87% | 96.9% | 203,765 | $935.0K | ||
| 39 | — | Shanghai Raas Blood Products Co Ltd | 0.82% | 97.8% | 1,236,034 | $885.1K | ||
| 40 | — | Cspc Innovation Pharmaceutical Co Ltd | 0.71% | 98.5% | 159,157 | $764.0K | ||
| 41 | — | Imeik Technology Development Co. Ltd. | 0.69% | 99.1% | 57,940 | $748.4K | ||
| 42 | — | Hangzhou Tiger-a | 0.50% | 99.6% | 71,850 | $536.8K | ||
| 43 | — | Cash | 0.15% | 99.8% | 157,516 | $157.5K | ||
| 44 | — | Kangmei Pharma - Rights O | 0.00% | 99.8% | 103,989 | - | ||
| 45 | — | Hong Kong Dollar | 0.00% | 99.8% | 911 | $116 | ||
KURE ETF All Holdings
KURE holdings total 45 positions. The top 10 holdings account for 53.0% of the fund, led by BeiGene Ltd at 8.9%, Innovent Biologics Inc at 8.0%, Wuxi Biologics (cayman) Inc. at 7.3%.
KURE portfolio concentration is relatively high, with the top 10 representing 53.0% of total assets. The largest sector exposure is Health Care at 15.9%.
KURE sectors provide a detailed breakdown. KURE overlap shows how holdings compare to other funds in your portfolio.
KURE ETF Holdings
45 of 45 holdings
- 1
BeiGene Ltd
6160:HKUnknown8.92% - 2
Innovent Biologics Inc
1801:HKHealth Care7.97% - 3
Wuxi Biologics (cayman) Inc.
2269:HKUnknown7.28% - 4
Wuxi Apptec Co. Ltd. Class A
603259:SHUnknown5.47% - 5
Jiangsu Hengrui Medicine Co Ltd Class A
600276:SHUnknown4.79% - 6
Shenzhen Mindray Bio-Medical Electronic
300760:SHUnknown4.62% - 7
Akeso Inc
9926:HKGUnknown3.90% - 8
Sino Biopharmaceutical Limited
1177:KYUnknown3.62% - 9
CSPC Pharmaceutical Group Limited Shs
1093:HKHealth Care3.39% - 10
Wuxi Apptec Co Ltd Class H
2359:HKUnknown3.08% - 11
Genscript Biotech Corp Class H
1548:HKUnknown3.04% - 12
Hansoh Pharmaceutical Group Co Ltd
3692:HKUnknown3.03% - 13
Yunnan Baiyao Group Co Ltd
000538:SHUnknown2.56% - 14
Shanghai United Imaging HE Class A
688271:SHUnknown2.51% - 15
Aier Eye Hospital Group Co Ltd
300015:SHUnknown2.14% - 16
Sichuan Kelun-Biotech Biop Class H
6990:SHUnknown2.04% - 17
3SBio Inc
1530:HKHealth Care2.03% - 18
Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A
600436:SHUnknown1.95% - 19
Sichuan Biokin Pharmaceutical Co.,Ltd.
688506:SHUnknown1.80% - 20
Sichuan Kelun Pharmaceutical Co. Ltd. Class A
002422:SHUnknown1.75% - 21
Pharmaron Beijing Ltd Class A
300759:SHUnknown1.67% - 22
Sinopharm Group Co Ltd
1099:HKHealth Care1.62% - 23
Haisco Pharmaceutical Group Co. Ltd. Class A
002653:HKUnknown1.37% - 24
Shenzhen New Industries Biomedical Engineering Co Ltd
300832:SHUnknown1.28% - 25
Shanghai Fosun Pharmaceuti-A
600196:SHUnknown1.26% - 26
Huadong Medicine Co Ltd
000963:SHUnknown1.24% - 27
Asymchem Laboratories Ltd
002821:SZUnknown1.24% - 28
Xtalpi Holdings Ltd Class A
2228:SHUnknown1.24% - 29
Shanghai Pharmaceuticals Holding Co. Ltd. Class A
601607:SHUnknown1.22% - 30
WuXi XDC Cayman Inc
2268:HKUnknown1.15% - 31
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
000999:SHUnknown1.13% - 32
Apt Medical Inc
688617:SHUnknown1.07% - 33
Shanghai Allist Pharmaceuticals Co Ltd
688578:SHUnknown1.00% - 34
Remegen Co., Ltd.
9995:SHUnknown0.94% - 35
Legend Biotech Corp ADR
LEGNHealth Care0.93% - 36
Beijing Tongrentang Co Ltd
600085:SHUnknown0.91% - 37
Remegen Co Ltd_None_None
688331:SHUnknown0.90% - 38
Shenzhen Salubris Pharmaceuticals Co Ltd
002294:SHUnknown0.87% - 39
Shanghai Raas Blood Products Co Ltd
002252:SHUnknown0.82% - 40
Cspc Innovation Pharmaceutical Co Ltd
300765:SHUnknown0.71% - 41
Imeik Technology Development Co. Ltd.
300896:SHUnknown0.69% - 42
Hangzhou Tiger-a
300347:SHUnknown0.50% - 43
Cash
Other0.15% - 44
Kangmei Pharma - Rights O
Other0.00% - 45
Hong Kong Dollar
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | BeiGene Ltd | 6160:HK | 8.920% | ||
| 2 | Innovent Biologics Inc | 1801:HK | 7.970% | ||
| 3 | Wuxi Biologics (cayman) Inc. | 2269:HK | 7.280% | ||
| 4 | Wuxi Apptec Co. Ltd. Class A | 603259:SH | 5.470% | ||
| 5 | Jiangsu Hengrui Medicine Co Ltd Class A | 600276:SH | 4.790% | ||
| 6 | Shenzhen Mindray Bio-Medical Electronic | 300760:SH | 4.620% | ||
| 7 | Akeso Inc | 9926:HKG | 3.900% | ||
| 8 | Sino Biopharmaceutical Limited | 1177:KY | 3.620% | ||
| 9 | CSPC Pharmaceutical Group Limited Shs | 1093:HK | 3.390% | ||
| 10 | Wuxi Apptec Co Ltd Class H | 2359:HK | 3.080% | ||
| 11 | Genscript Biotech Corp Class H | 1548:HK | 3.040% | ||
| 12 | Hansoh Pharmaceutical Group Co Ltd | 3692:HK | 3.030% | ||
| 13 | Yunnan Baiyao Group Co Ltd | 000538:SH | 2.560% | ||
| 14 | Shanghai United Imaging HE Class A | 688271:SH | 2.510% | ||
| 15 | Aier Eye Hospital Group Co Ltd | 300015:SH | 2.140% | ||
| 16 | Sichuan Kelun-Biotech Biop Class H | 6990:SH | 2.040% | ||
| 17 | 3SBio Inc | 1530:HK | 2.030% | ||
| 18 | Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. Class A | 600436:SH | 1.950% | ||
| 19 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 688506:SH | 1.800% | ||
| 20 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A | 002422:SH | 1.750% | ||
| 21 | Pharmaron Beijing Ltd Class A | 300759:SH | 1.670% | ||
| 22 | Sinopharm Group Co Ltd | 1099:HK | 1.620% | ||
| 23 | Haisco Pharmaceutical Group Co. Ltd. Class A | 002653:HK | 1.370% | ||
| 24 | Shenzhen New Industries Biomedical Engineering Co Ltd | 300832:SH | 1.280% | ||
| 25 | Shanghai Fosun Pharmaceuti-A | 600196:SH | 1.260% | ||
| 26 | Huadong Medicine Co Ltd | 000963:SH | 1.240% | ||
| 27 | Asymchem Laboratories Ltd | 002821:SZ | 1.240% | ||
| 28 | Xtalpi Holdings Ltd Class A | 2228:SH | 1.240% | ||
| 29 | Shanghai Pharmaceuticals Holding Co. Ltd. Class A | 601607:SH | 1.220% | ||
| 30 | WuXi XDC Cayman Inc | 2268:HK | 1.150% | ||
| 31 | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | 000999:SH | 1.130% | ||
| 32 | Apt Medical Inc | 688617:SH | 1.070% | ||
| 33 | Shanghai Allist Pharmaceuticals Co Ltd | 688578:SH | 1.000% | ||
| 34 | Remegen Co., Ltd. | 9995:SH | 0.940% | ||
| 35 | Legend Biotech Corp ADR | LEGN | 0.930% | ||
| 36 | Beijing Tongrentang Co Ltd | 600085:SH | 0.910% | ||
| 37 | Remegen Co Ltd_None_None | 688331:SH | 0.900% | ||
| 38 | Shenzhen Salubris Pharmaceuticals Co Ltd | 002294:SH | 0.870% | ||
| 39 | Shanghai Raas Blood Products Co Ltd | 002252:SH | 0.820% | ||
| 40 | Cspc Innovation Pharmaceutical Co Ltd | 300765:SH | 0.710% | ||
| 41 | Imeik Technology Development Co. Ltd. | 300896:SH | 0.690% | ||
| 42 | Hangzhou Tiger-a | 300347:SH | 0.500% | ||
| 43 | Cash | - | 0.150% | ||
| 44 | Kangmei Pharma - Rights O | - | 0.000% | ||
| 45 | Hong Kong Dollar | - | 0.000% |

